Todd Harris
CIK: 0001711463
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Tyra Biosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Sep 15, 2026TYRA
Tyra Biosciences, Inc.
Award(A)Direct864 shares at avg. $9.13$8K - May 5, 2026TYRA
Tyra Biosciences, Inc.
Award(A)Direct79K shares- - Mar 13, 2026TYRA
Tyra Biosciences, Inc.
Award(A)Direct1.5K shares at avg. $9.13$13K - Aug 7, 2025TYRA
Tyra Biosciences, Inc.
Award(A)DirectStock Option (Right to Buy)
570K shares- - Mar 14, 2025TYRA
Tyra Biosciences, Inc.
Award(A)Direct1.2K shares at avg. $9.78$12K - Oct 21, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct13.2K shares at avg. $28.16$371K - Oct 21, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct5.9K shares at avg. $27.32$161K - Oct 18, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct43.6K shares at avg. $27.01$1.2M - Oct 17, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct200 shares at avg. $26.37$5K - Oct 17, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct15.2K shares at avg. $25.84$393K - Oct 16, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct4.9K shares at avg. $25.22$124K - Oct 16, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct3.9K shares at avg. $26.98$106K - Oct 16, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct24.5K shares at avg. $26.23$642K - Oct 15, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct10K shares at avg. $24.31$244K - Sep 30, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct500 shares at avg. $24.00$12K - Sep 25, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct600 shares at avg. $24.01$14K - Sep 24, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct1.1K shares at avg. $24.02$25K - Sep 23, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct10.1K shares at avg. $24.13$243K - Sep 20, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct7.1K shares at avg. $24.19$172K - Sep 19, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct5.7K shares at avg. $24.30$138K - Sep 19, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct27 shares at avg. $25.10$677.616 - Sep 18, 2024TYRA
Tyra Biosciences, Inc.
Sale(S)Direct3.5K shares at avg. $24.00$84K - Sep 13, 2024TYRA
Tyra Biosciences, Inc.
Award(A)Direct1.4K shares at avg. $6.58$9K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 15, 2026 | TYRA Tyra Biosciences, Inc. | Award(A) | 864 | $9.13 | $7,887 | Direct |
| May 5, 2026 | TYRA Tyra Biosciences, Inc. | Award(A) | 79,000 | - | $0 | Direct |
| Mar 13, 2026 | TYRA Tyra Biosciences, Inc. | Award(A) | 1,463 | $9.13 | $13,356 | Direct |
| Aug 7, 2025 | TYRA Tyra Biosciences, Inc. | Award(A) Stock Option (Right to Buy) | 570,000 | - | - | Direct |
| Mar 14, 2025 | TYRA Tyra Biosciences, Inc. | Award(A) | 1,241 | $9.78 | $12,131 | Direct |
| Oct 21, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 13,188 | $28.16 | $371,370 | Direct |
| Oct 21, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 5,896 | $27.32 | $161,081 | Direct |
| Oct 18, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 43,636 | $27.01 | $1,178,796 | Direct |
| Oct 17, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 200 | $26.37 | $5,274 | Direct |
| Oct 17, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 15,194 | $25.84 | $392,598 | Direct |
| Oct 16, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 4,900 | $25.22 | $123,556 | Direct |
| Oct 16, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 3,922 | $26.98 | $105,811 | Direct |
| Oct 16, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 24,475 | $26.23 | $642,062 | Direct |
| Oct 15, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 10,035 | $24.31 | $243,970 | Direct |
| Sep 30, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 500 | $24.00 | $12,000 | Direct |
| Sep 25, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 600 | $24.01 | $14,406 | Direct |
| Sep 24, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 1,055 | $24.02 | $25,341 | Direct |
| Sep 23, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 10,092 | $24.13 | $243,477 | Direct |
| Sep 20, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 7,109 | $24.19 | $171,950 | Direct |
| Sep 19, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 5,671 | $24.30 | $137,813 | Direct |
| Sep 19, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 27 | $25.10 | $678 | Direct |
| Sep 18, 2024 | TYRA Tyra Biosciences, Inc. | Sale(S) | 3,500 | $24.00 | $84,000 | Direct |
| Sep 13, 2024 | TYRA Tyra Biosciences, Inc. | Award(A) | 1,350 | $6.58 | $8,882 | Direct |
1-23 of 23 transactions
About Harris Todd
Harris Todd (SEC CIK 0001711463) files insider reports with the SEC as President and CEO of Tyra Biosciences, Inc. (TYRA).
Signal8 holds 11 ownership filings by Harris Todd, all Form 4s, filed between Sep 17, 2024 and Sep 17, 2026. Those filings report 23 transactions, from Sep 13, 2024 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Harris Todd's filings is in CARLSBAD, CA.
Recent filings by Harris Todd
- Sep 15, 2026: Grant or award of TYRA shares (Form 4, code A).
- May 5, 2026: Grant or award of TYRA shares (Form 4, code A).
- Mar 13, 2026: Grant or award of TYRA shares (Form 4, code A).
- Aug 7, 2025: Grant or award of TYRA derivative securities (Form 4, code A).
- Mar 14, 2025: Grant or award of TYRA shares (Form 4, code A).
Other insiders filing for Tyra Biosciences, Inc. (TYRA)
- Rueb Yuliya, Vice President, Finance (PAO)
- Fuhrman Alan, Chief Financial Officer
- RA CAPITAL MANAGEMENT, L.P., Director
- Verjee Rehan, Director
- Moran Susan, Director
- Simson Jake, Director